Trial
NCT02410343
Study of TV-1106 in Growth Hormone-Deficient Adults
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Collaborators
—
Condition
Growth Hormone Deficiency
Intervention
TV-1106
Why stopped
Business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-24